Skip to main content

Displaying 2413 - 2424 of 12383

All Star Charts Premium,
2 to 100 Club

2 to 100 Club (10-11-2023)

October 11, 2023

From the Desk of Steve Strazza @Sstrazza

Welcome to The 2 to 100 Club.

As many of you know, something we've been working on internally is using various bottom-up tools and scans to complement our top-down approach.

It's really been working for us!

One way we're doing this is by identifying the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn't just end there.

We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.

Some of the best performers in recent decades – stocks like Priceline, Amazon, Netflix, Salesforce, and myriad others – would have been on this list at some point...

[Options] Getting Cautiously Long

October 11, 2023

[12/4/23: moving stop to 550]

Today's trade is a bet on stocks making a run back towards all-time highs over the next 3-6 months. If you don't believe that's in the cards for stocks, then this trade isn't for you.

Unfortunately, its also a trade in a stock with a high trading price, so the margin requirement may perhaps be a bit onerous for some.

If you're in either camp, there's no shame in skipping this trade. It's not for everyone.

If I haven't scared you off yet, then keep reading...

These are not random moves

October 11, 2023

Now is the time.

If stocks are going to go, this is when they usually do it.

The Dow Jones Industrial Average is only 9% from making a new all-time high.

So is the S&P500.

And what do I think the catalyst is going to be?

Let me rephrase that....

What do I think the catalyst needs to be?

A weaker US Dollar!

Cormorant Raises Its MLTX Stake to 15.2%

October 11, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management.

The hedge fund reported a $3.5 million purchase of MoonLake Immunotherapeutics $MLTX stock, increasing its ownership stake to 15.20%.

This Ratio Screams Risk On

October 10, 2023

From the Desk of Alfonso Depablos @Alfcharts

As the market has been sending mixed signals since July, we’re seeking information from our risk appetite indicators to try to gauge the next move.

One of our favorite ways to measure risk appetite is to compare the consumer discretionary sector with consumer staples. This tells us whether market participants are positioning themselves defensively, or embracing risk. 

Discretionary stocks include automobiles, retailers, and homebuilders, among other things. Theoretically, we’re talking about products and services consumers buy with their discretionary incomes. 

Meanwhile, staples are what "consumers" will buy regardless of how bad economic conditions get… things like food, toothpaste, cigarettes, etc.

When this ratio points higher, it illustrates a healthy degree of risk-seeking behavior among investors. Alternatively, when it points downwards, it speaks to a defensive tone and typically occurs during bear markets.

It's Quiet on the Insider Filings Front

October 10, 2023

From the Desk of Steve Strazza and Alfonso Depablos

With investors and executives scrambling to figure out what the geopolitical events of the weekend mean for their portfolios and companies, all was silent on the insider filings front. 

There were no Form 4s, Form 13s, or political reports that meet our materiality threshold.